European Capital Investment Review 2017: Pharmaceutical-Biotech Industry Launched $13 Billion in Capital Construction Starts

SUGAR LAND--February 5, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Considered a key component of Europe's industrial base, the European Pharmaceutical & Biotech Industry includes the development and production of pharmaceuticals, biologicals, medical devices and cosmetics. Continuing to return a healthy capital expenditure investment profile along with consistent project activity, Europe launched nearly $13 billion in capital and maintenance Pharma-Biotech projects in 2017.

Within this article: Examples of European Pharma-Biotech projects